|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.30 AUD | +3.73% |
|
+14.96% | -17.34% |
| 06-15 | Clinuvel Pharmaceuticals Advances US Listing Plan With SEC Filing for Nasdaq ADS Upgrade | MT |
| 04-27 | Clinuvel Pharmaceuticals plans level II ADR upgrade and Nasdaq listing as CUVL | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 10.47 | 10.75 | 11 |
| Spread/Res. | -1.62% | -4.19% | -6.36% |
| Spread/Supp. | +7.29% | +18.12% | +14.96% |
| Support | 9.6 | 8.72 | 8.96 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- CUV Stock
- Charts Clinuvel Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
